Press Releases
Stay informed with the latest news and updates from the California Institute for Regenerative Medicine (CIRM). For media inquiries or additional information, contact the CIRM communications team at press@cirm.ca.gov. For even more breaking news, visit our blog, The Stem Cellar.
January 24, 2022
California Institute for Regenerative Medicine and the Davos Alzheimer’s Collaborative Release a Statement of Interest to Advance Brain Research
California Institute for Regenerative Medicine and the Davos Alzheimer’s Collaborative Release a Statement of Interest to Advance Brain Research
December 14, 2021
Stem Cell Agency Board Approves Roadmap for Next Five Years; Invests $5M in High School Internships
Stem Cell Agency Board Approves Roadmap for Next Five Years; Invests $5M in High School Internships
September 23, 2021
Stem Cell Agency Funds Clinical Trial Targeting Blood Cancers in Children and Young Adults
Stem Cell Agency Funds Clinical Trial Targeting Blood Cancers in Children and Young Adults
July 20, 2021
Board Funds Fifteen Bridges to Stem Cell Research and Therapy Programs Across California and New Sickle Cell Disease Trial
Board Funds Fifteen Bridges to Stem Cell Research and Therapy Programs Across California and New Sickle Cell Disease Trial
June 24, 2021
CIRM Adds Five New Hires, including VP Scientific Programs and a Decorated Veteran, to Build Out Its World Class Team
CIRM Adds Five New Hires, including VP Scientific Programs and a Decorated Veteran, to Build Out Its World Class Team
May 28, 2021
Statement from Dr. Maria Millan on the News of Orchard Returning the Treatment for ADA-SCID to UCLA
Statement from Dr. Maria Millan on the News of Orchard Returning the Treatment for ADA-SCID to UCLA
May 14, 2021
Industry Executive Kevin Marks joins CIRM as General Counsel during the Agency’s first wave of strategic growth
Industry Executive Kevin Marks joins CIRM as General Counsel during the Agency’s first wave of strategic growth
May 12, 2021
Medeor Therapeutics Completes Enrollment in CIRM-Funded Clinical Trial for Kidney Transplant Patients
Medeor Therapeutics Completes Enrollment in CIRM-Funded Clinical Trial for Kidney Transplant Patients
May 11, 2021
New Study Shows CIRM-Supported Therapy Cures More than 95% of Children Born with a Fatal Immune Disorder.
New Study Shows CIRM-Supported Therapy Cures More than 95% of Children Born with a Fatal Immune Disorder.
December 14, 2020
CIRM-Funded Project Targeting Sickle Cell Disease Gets Green Light for Clinical Trial
CIRM-Funded Project Targeting Sickle Cell Disease Gets Green Light for Clinical Trial
November 18, 2020
CIRM-Funded Clinical Trial for Sickle Cell Gives Hope to People Battling the Disease
CIRM-Funded Clinical Trial for Sickle Cell Gives Hope to People Battling the Disease
September 8, 2020
California’s Stem Cell Agency and the Chan Zuckerberg Initiative Partner to Create COVID-19 Database
California’s Stem Cell Agency and the Chan Zuckerberg Initiative Partner to Create COVID-19 Database
March 27, 2020
Stem Cell Agency Board Approves $5 Million in Emergency Funding for COVID-19 Research
Stem Cell Agency Board Approves $5 Million in Emergency Funding for COVID-19 Research
December 16, 2019
Journalism Pioneer and Founder of Latino Cancer Institute Joins Stem Cell Agency Board
Journalism Pioneer and Founder of Latino Cancer Institute Joins Stem Cell Agency Board
October 31, 2019
Stem Cell Agency Approves Funding for Clinical Trials Targeting Parkinson’s Disease and Blindness
Stem Cell Agency Approves Funding for Clinical Trials Targeting Parkinson’s Disease and Blindness
October 9, 2019
New Report Says Stem Cell Agency Produces Measurable Economic Benefits for California
New Report Says Stem Cell Agency Produces Measurable Economic Benefits for California
May 1, 2019
CIRM Board Approves Funding for New Clinical Trials in Solid Tumors and Pediatric Disease
CIRM Board Approves Funding for New Clinical Trials in Solid Tumors and Pediatric Disease
